Cargando…

Novel measure of lung function for assessing disease activity in asthma

INTRODUCTION: In asthma, lung function measures are often discordant with clinical features such as disease activity or control. METHODS: We investigated a novel technique that provides a measure (σCL) of unevenness (inhomogeneity) in lung inflation/deflation. In particular, we compared σCL with FEV...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Nicholas M J, Couper, John, Fullerton, Christopher J, Richmond, Graham, Talbot, Nick P, Hancock, Gus, Pavord, Ian, Ritchie, Grant A D, Robbins, Peter A, Petousi, Nayia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066624/
https://www.ncbi.nlm.nih.gov/pubmed/32161066
http://dx.doi.org/10.1136/bmjresp-2019-000531
_version_ 1783505280753991680
author Smith, Nicholas M J
Couper, John
Fullerton, Christopher J
Richmond, Graham
Talbot, Nick P
Hancock, Gus
Pavord, Ian
Ritchie, Grant A D
Robbins, Peter A
Petousi, Nayia
author_facet Smith, Nicholas M J
Couper, John
Fullerton, Christopher J
Richmond, Graham
Talbot, Nick P
Hancock, Gus
Pavord, Ian
Ritchie, Grant A D
Robbins, Peter A
Petousi, Nayia
author_sort Smith, Nicholas M J
collection PubMed
description INTRODUCTION: In asthma, lung function measures are often discordant with clinical features such as disease activity or control. METHODS: We investigated a novel technique that provides a measure (σCL) of unevenness (inhomogeneity) in lung inflation/deflation. In particular, we compared σCL with FEV(1)% predicted (FEV(1)%pred) as measures of disease activity in the asthmatic lung. RESULTS: σCL correlated modestly with FEV(1)%pred. However, σCL is not simply a proxy for FEV(1)%pred as the effects of salbutamol on the two parameters were unrelated. Importantly, σCL reflected disease control better than FEV(1). DISCUSSION: We conclude that σCL shows promise as an objective measure of disease activity in asthma.
format Online
Article
Text
id pubmed-7066624
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-70666242020-03-20 Novel measure of lung function for assessing disease activity in asthma Smith, Nicholas M J Couper, John Fullerton, Christopher J Richmond, Graham Talbot, Nick P Hancock, Gus Pavord, Ian Ritchie, Grant A D Robbins, Peter A Petousi, Nayia BMJ Open Respir Res Asthma INTRODUCTION: In asthma, lung function measures are often discordant with clinical features such as disease activity or control. METHODS: We investigated a novel technique that provides a measure (σCL) of unevenness (inhomogeneity) in lung inflation/deflation. In particular, we compared σCL with FEV(1)% predicted (FEV(1)%pred) as measures of disease activity in the asthmatic lung. RESULTS: σCL correlated modestly with FEV(1)%pred. However, σCL is not simply a proxy for FEV(1)%pred as the effects of salbutamol on the two parameters were unrelated. Importantly, σCL reflected disease control better than FEV(1). DISCUSSION: We conclude that σCL shows promise as an objective measure of disease activity in asthma. BMJ Publishing Group 2020-03-10 /pmc/articles/PMC7066624/ /pubmed/32161066 http://dx.doi.org/10.1136/bmjresp-2019-000531 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Asthma
Smith, Nicholas M J
Couper, John
Fullerton, Christopher J
Richmond, Graham
Talbot, Nick P
Hancock, Gus
Pavord, Ian
Ritchie, Grant A D
Robbins, Peter A
Petousi, Nayia
Novel measure of lung function for assessing disease activity in asthma
title Novel measure of lung function for assessing disease activity in asthma
title_full Novel measure of lung function for assessing disease activity in asthma
title_fullStr Novel measure of lung function for assessing disease activity in asthma
title_full_unstemmed Novel measure of lung function for assessing disease activity in asthma
title_short Novel measure of lung function for assessing disease activity in asthma
title_sort novel measure of lung function for assessing disease activity in asthma
topic Asthma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066624/
https://www.ncbi.nlm.nih.gov/pubmed/32161066
http://dx.doi.org/10.1136/bmjresp-2019-000531
work_keys_str_mv AT smithnicholasmj novelmeasureoflungfunctionforassessingdiseaseactivityinasthma
AT couperjohn novelmeasureoflungfunctionforassessingdiseaseactivityinasthma
AT fullertonchristopherj novelmeasureoflungfunctionforassessingdiseaseactivityinasthma
AT richmondgraham novelmeasureoflungfunctionforassessingdiseaseactivityinasthma
AT talbotnickp novelmeasureoflungfunctionforassessingdiseaseactivityinasthma
AT hancockgus novelmeasureoflungfunctionforassessingdiseaseactivityinasthma
AT pavordian novelmeasureoflungfunctionforassessingdiseaseactivityinasthma
AT ritchiegrantad novelmeasureoflungfunctionforassessingdiseaseactivityinasthma
AT robbinspetera novelmeasureoflungfunctionforassessingdiseaseactivityinasthma
AT petousinayia novelmeasureoflungfunctionforassessingdiseaseactivityinasthma